T1	Intervention 18 95	impact of vaginal and oral administration of combined hormonal contraceptives
T2	Intervention 167 316	effects of a new combined hormonal contraceptive vaginal ring (CVR) delivering the nonandrogenic progestin Nestorone (NES) and ethinyl estradiol (EE)
T3	Intervention 953 1107	randomized to three cycles of treatment with a CVR delivering NES/EE (150/15 microg/day) or a combined OC providing LNG and EE (150/30 microg per tablet).
T4	Intervention 1108 1197	Each cycle consisted of 21 days of active treatment, followed by 7 days without treatment
